Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What you need to know about the coronavirus right now

Published 18/12/2020, 04:55 pm

Dec 18 (Reuters) - Here's what you need to know about the coronavirus right now:

FDA panel sets stage for Moderna MRNA.O vaccine authorization

The U.S. Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna's vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.

A panel of outside advisers to the FDA overwhelmingly endorsed the emergency use of Moderna's vaccine, virtually assuring a second option for protecting against COVID-19. virus cluster grows

Christmas travel plans for thousands of Australians were thrown into chaos on Friday when states and territories imposed border restrictions after 28 COVID-19 cases were detected in Sydney, with fears infections could spread citywide.

Around a quarter of a million people in Sydney's northern beaches, where the cases have been found, have been told to stay home and wear masks if in other venues.

"Everyone in greater Sydney needs to be on high alert," New South Wales state Premier Gladys Berejiklian told a news conference on Friday in announcing 10 new cases. post-pandemic normal in France before autumn 2021

France is unlikely to return to normal life before autumn next year as it could take longer than initially envisioned to roll out vaccines, a senior government scientific adviser said on Friday.

"Vaccines are a major source of hope but if you look at the vaccination capabilities that we will have in France and elsewhere in Europe, we will need time," immunologist Jean-François Delfraissy told BFM television.

Delfraissy estimated there were 22 million people in France more vulnerable than others and that it could take until May to vaccinate them all, before shots could be rolled out to others. English lockdown can't be ruled out, minister suggests

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A new national lockdown in England cannot be ruled out after Christmas, British schools minister Nick Gibb said on Friday, although he stressed that the current regional "tiered" system of restrictions was effective.

Northern Ireland and Wales have both outlined plans to head back into lockdown after Christmas, raising suggestions that England might follow suit. told Sky News that "nothing is ruled out of course as we tackle this pandemic" but added that the tier system is very effective.

Six South Koreans die of COVID awaiting hospital beds

Six people suffering from COVID-19 have died in South Korea this month while waiting for hospital beds and hundreds can not get admitted as surging infections overload the health system, officials and media said on Friday.

South Korea reported 1,062 new cases on Friday, its second-highest ever daily tally, as the government agonised over tighter restrictions and warned businesses it was unacceptable to try to dodge shut-down orders.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.